TIAA CREF Investment Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $3.94M | Sell |
84,655
-34,175
| -29% | -$1.59M | ﹤0.01% | 1594 |
|
2018
Q4 | $5.18M | Sell |
118,830
-1,954
| -2% | -$85.1K | ﹤0.01% | 1353 |
|
2018
Q3 | $6.91M | Buy |
120,784
+17,986
| +17% | +$1.03M | ﹤0.01% | 1356 |
|
2018
Q2 | $4.99M | Buy |
102,798
+15,987
| +18% | +$776K | ﹤0.01% | 1599 |
|
2018
Q1 | $3.39M | Sell |
86,811
-216
| -0.2% | -$8.45K | ﹤0.01% | 1806 |
|
2017
Q4 | $3.69M | Buy |
87,027
+3,178
| +4% | +$135K | ﹤0.01% | 1793 |
|
2017
Q3 | $3.13M | Sell |
83,849
-2,362
| -3% | -$88.1K | ﹤0.01% | 1904 |
|
2017
Q2 | $2.62M | Sell |
86,211
-12,532
| -13% | -$381K | ﹤0.01% | 2023 |
|
2017
Q1 | $2.61M | Buy |
98,743
+20,189
| +26% | +$534K | ﹤0.01% | 1971 |
|
2016
Q4 | $2.01M | Sell |
78,554
-5,142
| -6% | -$131K | ﹤0.01% | 2191 |
|
2016
Q3 | $3.03K | Sell |
83,696
-16,496
| -16% | -$597 | ﹤0.01% | 1923 |
|
2016
Q2 | $3.41M | Buy |
100,192
+10,605
| +12% | +$360K | ﹤0.01% | 1801 |
|
2016
Q1 | $2.36M | Buy |
89,587
+20,263
| +29% | +$535K | ﹤0.01% | 1976 |
|
2015
Q4 | $3.38M | Sell |
69,324
-2,009
| -3% | -$98K | ﹤0.01% | 1823 |
|
2015
Q3 | $1.78M | Sell |
71,333
-1,726
| -2% | -$43K | ﹤0.01% | 2222 |
|
2015
Q2 | $2.31M | Buy |
73,059
+15,653
| +27% | +$495K | ﹤0.01% | 2211 |
|
2015
Q1 | $2.19M | Hold |
57,406
| – | – | ﹤0.01% | 2166 |
|
2014
Q4 | $2.24M | Sell |
57,406
-2,782
| -5% | -$108K | ﹤0.01% | 2164 |
|
2014
Q3 | $1.82M | Sell |
60,188
-13,327
| -18% | -$403K | ﹤0.01% | 2281 |
|
2014
Q2 | $2.5M | Buy |
73,515
+36,374
| +98% | +$1.24M | ﹤0.01% | 2168 |
|
2014
Q1 | $1.28M | Sell |
37,141
-11,929
| -24% | -$411K | ﹤0.01% | 2499 |
|
2013
Q4 | $1.94M | Buy |
+49,070
| New | +$1.94M | ﹤0.01% | 2273 |
|